CLS carries out hands-on workshop at CIRSE in Lisbon, Portugal, 22-25 September 2018

Clinical Laserthermia Systems (CLS) (publ), participates in the CIRSE conference in Lisbon, Portugal, 22-25 September 2018. CLS demonstrates its TRANBERG®|Thermal Therapy System in front of interested physicians and other medical professionals in a hands-on workshop.

-   We see a great value in participating in these kind of workshops, where experts in interventional radiology, in an educational format, can get a live experience of the benefits with our product, said Karin Peterson, Chief Product Officer at CLS. The conference of course also provides an excellent opportunity for us to meet potential as well as existing business contacts from both Europe and the U.S., concludes Karin Peterson. 

TRANBERG®|Thermal Therapy System consists of a small, user-friendly laser unit together with custom-designed instruments and single-use products, developed for precise, gentle and effective treatment with the CLS’ own method, imILT®, as well as with image-guided focal laser ablation (FLA).

CLS’ workshop takes place on Tuesday, 25 September, HDT 5, ”Tumor Ablation  - Cryo ablation, laser ablation and irreversible electroporation”, Auditorium 3, at 9:30 – 11:00 AM. CLS is since a few years back a member of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) who is organising this event. Last year’s meeting, in Copenhagen, attracted 7000 attendees from about 50 countries, whereof some 30% from Asia and the U.S. Read more about CIRSE

Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 – (0)702 – 90 33 00   E-mail: lee@clinicallaser.se

Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and have subsidiaries in Berlin, Germany and Boston, MA,USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s website: www.clinicallaser.se